Volume 16, Number 7—July 2010
Synopsis
Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia
Table 1
Patient no. | Age, y/sex | Underlying malignancy | Coexisting conditions | Acquisition | Radiographic infiltrates | ICU | Death |
---|---|---|---|---|---|---|---|
Allogeneic stem cell transplant recipients | |||||||
1 | 44/F | Prolymphocytic leukemia | GVHD, renal | Community† | None | Yes | Yes |
2 | 53/F | Non-Hodgkin lymphoma | GVHD‡ | Nosocomial | Multifocal | Yes | Yes |
3 | 33/M | Hodgkin lymphoma | None | Community | None | No | No |
4 | 57/F | CML | GVHD§ | Community | Unifocal | No | No |
5 | 61/M | Myelodysplastic syndrome | None | Nosocomial | Multifocal | Yes | Yes |
6 | 56/M | Myelofibrosis | GVHD‡ | Community | Multifocal | Yes | Yes |
7 | 61/M | AML | GVHD,§ cardiac | Community | None | No | No |
8 |
63/F |
AML |
None |
Nosocomial |
Unifocal |
Yes |
No |
Autologous stem cell transplant recipients | |||||||
9 | 70/M | Multiple myeloma | Pulmonary | Community† | Unifocal | Yes | No |
10 | 50/F | Multiple myeloma | None | Community | Multifocal | Yes | Yes |
11 | 72/M | Multiple myeloma | Type 2 diabetes | Community | None | No | No |
12 | 42/F | Multiple myeloma | Type 2 diabetes | Community | Multifocal | Yes | No |
13 | 57/M | Multiple myeloma | None | Community† | Multifocal | No | No |
14 | 30/F | Hodgkins lymphoma | None | Community | Multifocal | No | No |
15 | 52/F | Non-Hodgkins lymphoma | None | Community | None | No | No |
16 |
68/M |
Multiple myeloma |
Renal |
Community |
Multifocal |
Yes |
Yes |
Patients with no prior stem cell transplant | |||||||
17 | 24/F | Hodgkins lymphoma | None | Community¶ | None | No | No |
18 | 72/M | AML | Type 2 diabetes | Community | Multifocal | No | No |
19 | 63/F | Multiple myeloma | None | Community | Multifocal | No | No |
20 | 80/F | Aplastic anemia | Cardiac | Community | None | No | No |
21 | 70/F | Hodgkins lymphoma | None | Community | None | No | No |
22 | 61/F | CLL | None | Community† | Multifocal | No | No |
23 | 63/F | Non-Hodgkin lymphoma | Pulmonary | Community† | None | No | No |
24 | 68/M | CLL | Pulmonary | Community | None | Yes | Yes |
25 | 76/M | CLL | Pulmonary | Community | Multifocal | No | No |
26 | 59/F | AML | None | Community | None | No | No |
27 | 47/F | CLL | None | Community | No imaging | No | No |
28 | 57/M | Multiple myeloma | None | Community | Unifocal | No | No |
29 | 56/M | Hodgkin lymphoma | Type 2 diabetes | Community | Multifocal | No | No |
30 | 26/M | ALL | None | Nosocomial | No imaging | No | No |
31 | 55/F | Cervical cancer | None | Community | None | No | No |
32 | 50/F | Breast cancer | None | Community | Multifocal | No | No |
*HSCT, hematopoietic stem cell transplant; ICU, intensive care unit; GVHD, graft-versus-host disease; CML, chronic myeloid leukemia; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; ALL, acute lymphocytic leukemia.
†Household contacts with influenza-like illness identified.
‡Severe GVHD.
§Chronic GVHD.
¶Patient 17 had onset of influenza-like symptoms on returning to Victoria from interstate travel.
Page created: March 02, 2011
Page updated: March 02, 2011
Page reviewed: March 02, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.